Karo Pharma completed the acquisition of Avista-backed Trimb for $362m.

Karo Pharmacy, a specialty pharma company, completed the acquisition of Avista Capital-backed Trimb Holding, a consumer healthcare company for $362m. The Transaction is expected to contribute positively to Karo Pharma’s market position and create a strong platform for Karo Pharma’s continued growth. “Trimb is a distinguished company within over-the-counter pharmaceuticals and consumer healthcare products. Over the past years, the company has successfully built a Nordic business and a growing presence in Northern Europe. Trimb complements Karo Pharma well, both in terms of geographical presence, distribution channels and product offering. I look forward to continuing this journey in a combined company,” Christoffer Lorenzen, Karo Pharma CEO.